In November 2021, the drug firm had said that it had received an order to supply one crore doses of its coronavirus vaccine to the government at Rs 265 per dosefrom Moneycontrol Business News https://ift.tt/iQ8EcTqyW
Tuesday, February 1, 2022
Subscribe to:
Post Comments (Atom)
LTIMindtree Q4 Preview: Lower pass-through revenue seen impacting growth marginally
A compilation of estimates suggests the company#39;s Q4 FY24 net profit is projected to decline by 2.2 percent quarter on quarter to Rs 1,1...
-
In a regulatory filing the company said the Odisha Electricity Regulatory Commission (OERC) has awarded the Letter of Intent (LOI) to Tata ...
-
A compilation of estimates suggests the company#39;s Q4 FY24 net profit is projected to decline by 2.2 percent quarter on quarter to Rs 1,1...
No comments:
Post a Comment